{
    "Trade/Device Name(s)": [
        "MEDTOX Buprenorphine Test"
    ],
    "Submitter Information": "MEDTOX Diagnostics, Inc.",
    "510(k) Number": "K100951",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060466"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG"
    ],
    "Summary Letter Date": "September 23, 2010",
    "Summary Letter Received Date": "September 24, 2010",
    "Submission Date": "September 22, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine",
        "Buprenorphine-glucuronide",
        "Norbuprenorphine",
        "Norbuprenorphine-glucuronide"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Qualitative screening",
        "Visual interpretation"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for MEDTOX Buprenorphine Test, a qualitative immunochromatographic assay for detection of buprenorphine and its metabolites in human urine.",
    "Indications for Use Summary": "For rapid, qualitative detection of buprenorphine and its metabolites in human urine for prescription use only; not for over-the-counter sale or point-of-care settings.",
    "fda_folder": "Toxicology"
}